Gilles Peytavin

Gilles Peytavin

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 214 publications

A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.

A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.

Journal: Antimicrobial agents and chemotherapy

Published: June 10, 2026

Drug interactions and kidney safety of bictegravir/emtricitabine/tenofovir alafenamide in kidney transplant recipients with HIV: an interventional pilot study.

Drug interactions and kidney safety of bictegravir/emtricitabine/tenofovir alafenamide in kidney transplant recipients with HIV: an interventional pilot study.

Journal: The Journal of antimicrobial chemotherapy

Published: May 22, 2026

Drug-Drug Interaction Between Praziquantel and Nevirapine in HIV-Schistosomiasis Co-infection: A Pharmacokinetic case report.

Drug-Drug Interaction Between Praziquantel and Nevirapine in HIV-Schistosomiasis Co-infection: A Pharmacokinetic case report.

Journal: Journal of travel medicine

Published: May 15, 2026

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Journal: Antiviral therapy

Published: May 13, 2026

Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program a.

Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program a.

Journal: Open forum infectious diseases

Published: April 29, 2026

Lenacapavir Use in France: A National, Observational Study (LENAddOn).

Lenacapavir Use in France: A National, Observational Study (LENAddOn).

Journal: Open forum infectious diseases

Published: April 23, 2026

Drug interaction between maribavir and rifampin: a case report.

Drug interaction between maribavir and rifampin: a case report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 28, 2026

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

Journal: Open forum infectious diseases

Published: March 27, 2026

HBV reactivation after switching to cabotegravir plus rilpivirine therapy among people living with HIV: do not forget the reservoir.

HBV reactivation after switching to cabotegravir plus rilpivirine therapy among people living with HIV: do not forget the reservoir.

Journal: The Journal of antimicrobial chemotherapy

Published: February 15, 2026

Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

Journal: The Journal of antimicrobial chemotherapy

Published: January 12, 2026

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Pregnant Women Infected with HIV-1: Real-Life Use.

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Pregnant Women Infected with HIV-1: Real-Life Use.

Journal: AIDS research and human retroviruses

Published: November 21, 2025

Minimal impact of pregnancy on rilpivirine pharmacokinetics in women living with HIV.

Minimal impact of pregnancy on rilpivirine pharmacokinetics in women living with HIV.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 19, 2025

Showing 1-12 of 214

Last Updated: 09/26/2026